- Microneedle-mediated co-delivery of biomimetic melanin and pro-regenerative factors for oxidative and immune modulation in vitiligo. [Journal Article]Mater Today Bio. 2026 Dec; 41:103757.MT
- Vitiligo lesions are characterized by elevated epidermal oxidative stress, cytotoxic immune activation, and impaired melanogenesis, while conventional topical therapies often fail to modulate these pathogenic events due to limited skin penetration and therapeutic depth. To address these challenges, a dual-layer gelatin methacryloyl (GelMA)/hyaluronic acid methacryloyl (HAMA)//hyaluronic acid (HA)…
- PMC Free PDF
- Carum carvi L. alleviates skin depigmentation by suppressing STAT1-mediated inflammatory responses. [Journal Article]J Ethnopharmacol. 2026 Oct 20; 374(Pt 3):122555. [Online ahead of print]JE
- CONCLUSIONS: CCL and its active monomer Rob effectively mitigates immune-mediated melanocyte destruction and promotes repigmentation. Rob drives targeted therapeutic intervention by suppressing the STAT1-macrophage-CD8[+] T cell inflammatory axis. These findings suggest CCL as a promising, multi-targeted natural therapy for vitiligo.
- Publisher Full Text (DOI)
- Factors correlating with patient satisfaction in monobenzone depigmentation for vitiligo: A retrospective cohort study. [Journal Article]J Am Acad Dermatol. 2026 Nov; 95(5):1498-1499.JA
- Publisher Full Text (DOI)
- Resveratrol-loaded novasomal gel for sustained dermal delivery against monobenzone-induced vitiligo-like depigmentation in black chicks. [Journal Article]
- Vitiligo is a multifactorial depigmenting disorder characterized by melanocyte loss, oxidative stress, and impaired melanogenesis. Resveratrol (RVT) exhibits potent antioxidant and cytoprotective properties; however, its topical application is limited by its poor cutaneous penetration, rapid degradation, and limited local bioavilability. To overcome these limitations, we developed a resveratrol-l…
- Publisher Full Text (DOI)
- Bittersweet: how hyperglycemia exacerbates vitiligo progression through the succinate/SUCNR1 axis. [Comment]J Clin Invest. 2026 Jun 15; 136(12).JCI
- Vitiligo is a depigmenting disease marked by progressive T cell-driven destruction of melanocytes in the skin, hair, and mucosa. While vitiligo is known to be a T cell-mediated autoimmune disease, its triggers have remained poorly understood and treatment options limited. In this issue of the JCI, Kang et al. demonstrated how hyperglycemia exacerbates vitiligo progression through the succinate/SU…
- Publisher Full Text (DOI)
- Sappanone A exerted promising therapeutic effects in vitiligo through Wnt5a-mediated noncanonical Wnt signaling. [Journal Article]
- Vitiligo is a skin disease characterized by the loss of skin melanocytes, featuring the dual pathology of melanocyte damage due to oxidative stress and immune-mediated inflammation, which ultimately classifies it as an autoimmune condition. Sappanone A (SA), isolated from Caesalpinia sappan L., exhibits notable anti-oxidative stress and anti-inflammatory activity in various diseases. However, its…
- Publisher Full Text (DOI)
- Multi-Omics Analyses Identify ANLN as a Prognostic Biomarker for Recurrence and Metastasis in Non-Small Cell Lung Cancer. [Journal Article]
- CONCLUSIONS: ANLN is a potential regulator of lung cancer recurrence and metastasis and marks a conserved invasion-prone epithelial state. ANLN-associated pathways may represent potential therapeutic targets in lung cancer.
- PMC Free PDF
- Tofacitinib citrate nanoemulgel induced repigmentation in vitiligo: Assessment of oxidative stress, protein, immunohistochemistry, and mRNA expressions. [Journal Article]Int J Pharm. 2026 Apr 10; 694:126719.IJ
- Tofacitinib citrate (TC), a selective inhibitor of Janus kinase 1/3 (JAK1/3), has gained attention as a potential treatment option for vitiligo, although systemic adverse effects remain a concern with oral therapy. To address this limitation, the current study focused on the development of a tofacitinib citrate-loaded nanoemulsion (TC-NE) incorporating black seed oil (BSO), a major source of thym…
- Publisher Full Text (DOI)
- Clematis Tangutica (Maxim.) Korsh. extracts promote melanogenesis via PKA/CREB activation and multi-cytokine inhibition: A novel dual targeting strategy for vitiligo therapy. [Journal Article]
- CONCLUSIONS: C. tangutica extract promotes melanogenesis via PKA/CREB activation and uniquely exhibits immunomodulatory activity in a vitiligo model. This study provides the first mechanistic evidence for the dual-targeting potential of C. tangutica, as a natural candidate for vitiligo therapy. Our findings highlight a novel phytotherapeutic strategy pigmentary disorders.
- Publisher Full Text (DOI)
- Hydroxypropyl-β-cyclodextrin co-delivery hydrogel of crisaborole and curcumin for combinational antioxidant/anti-inflammatory therapy of vitiligo. [Journal Article]
- Vitiligo is a depigmenting autoimmune disease driven by oxidative stress and immune-mediated melanocyte destruction. Current therapies are limited by poor drug permeability, systemic side effects, and insufficient efficacy. Herein, we developed a novel carbomer-based hydroxypropyl-β-cyclodextrin-encapsulated crisaborole/curcumin hydrogel (Cri/Cur@CD-Gel) for combinational transdermal intervention…
- PMC Free PDF
- Role of Autophagy Induced by Pmel17 in the Pathogenesis of Vitiligo. [Journal Article]
- CONCLUSIONS: The findings demonstrate that downregulation of Pmel17 contributes to the pathogenesis of vitiligo by inducing autophagy and inhibiting melanin synthesis, through the suppression of the PI3K-AKT-mTOR signaling pathway. These results provide new insights into the molecular mechanism between Pmel17 dysfunction and depigmentation.
- PMC Free PDF
- Berberine chloride nanoemulgel enriched with clove oil attenuated monobenzone-induced experimental vitiligo in C57BL/6 mice: Pharmaceutical, molecular modeling, biochemical, protein, and mRNA expression analysis. [Journal Article]Int J Pharm. 2025 Oct 15; 683:126048.IJ
- Vitiligo causes progressive loss of pigmentation owing to the destruction of melanocytes. Berberine chloride (BRB) protects melanocytes from oxidative stress and enhances melanophores. However, BRB exhibited reduced skin permeation efficiency due to poor (pKa-2.47 and 15.7; log P--1.5) physicochemical attributes. Therefore, in the present investigation, berberine chloride nanoemulsion (BRB-NE) en…
- Publisher Full Text (DOI)
- Photochromic Cu-TiO2 Nanocatalysts for Visible-Light-Triggered C-Cl Activation and Selective Molecular Assembly. [Journal Article]ACS Nano. 2025 Aug 12; 19(31):28719-28729.AN
- The efficient photoactivation of C-Cl bonds to selectively form C-C and C-O bonds via cross-coupling has emerged as a promising strategy for photosynthesizing pharmaceuticals. However, achieving selective cross-coupling of unactivated C-Cl bonds using visible light in a photoredox system remains a formidable challenge. Herein, we report a cooperative photoredox catalysis system that efficiently a…
- Publisher Full Text (DOI)
- Filiform fire needling therapy relieves T cells-mediated melanocyte apoptosis and dysfunction by inhibiting JAK/STAT3 pathway via Mfsd4a in vitiligo. [Journal Article]
- We investigated the molecular mechanism of filiform fire needling therapy (FFN), an effective treatment option for vitiligo, focusing on its role in relieving depigmentation. Firstly, we validated the efficacy and safety of FFN in a study with 11 enrolled vitiligo patients. We then found that the depigmentation score was significantly improved in monobenzone-induced vitiligo mice treated with FFN…
- Publisher Full Text (DOI)
- Dupilumab's Successful Journey in Pityriasis Lichenoides Chronica Followed by the Intriguing Reemergence of Vitiligo after Monobenzone Depigmentation: A Case Report. [Journal Article]
- CONCLUSIONS: This case highlights dupilumab's potential as an effective treatment for PLC and its possible role in promoting skin repigmentation in a patient with prior vitiligo. These findings suggest a potential link between type 2 inflammation and PLC pathogenesis, warranting further investigation. Dupilumab may represent a promising therapeutic alternative for refractory PLC.
- PMC Free PDF
